Pancreatic Cancer Research

ResearcherJikei University School of MedicineActive in the last 2 years

Tomohiko Taniai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8911-5530; OpenAlex author ID A5035412737. Sources: OpenAlex.

Their work

Papers
14
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 4 papers · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 4 papers

Papers 14

  1. Number of Liver Metastases Stratifies Prognosis in Synchronous Metastatic Pancreatic Cancer. Co-author DOI 10.1002/wjs.70666↗
  2. The Goddard score for emphysema predicts the postoperative prognosis in pancreatic cancer. Co-author DOI 10.1007/s00595-025-03188-7↗
  3. Clinical and Functional Impact of CHMP3 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-026-20340-w↗
  4. ASO Visual Abstract: Clinical and Functional Impact of CHMP3 in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1245/s10434-026-20399-5↗
  5. The minimum apparent diffusion coefficient value on preoperative magnetic resonance imaging in resectable pancreatic cancer: a new prognostic factor for biolog… Co-author DOI 10.1007/s00595-025-03050-w↗
  6. The Significant Impact of Fibrinogen-C-Reactive Protein-Albumin Ratio on the Long-Term Outcomes After Pancreatic Resection for Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000002416↗
  7. Prognostic significance of occult vertebral fracture in patients undergoing pancreatic resection for pancreatic cancer. Co-author DOI 10.1016/j.pan.2024.01.003↗
  8. Superior mesenteric vein/portal vein contact in preoperative imaging indicates biological malignancy in anatomically resectable pancreatic cancer. Co-author DOI 10.1016/j.suronc.2023.101998↗
  9. Inhibition of lysosomal acid β-glucosidase induces cell apoptosis via impairing mitochondrial clearance in pancreatic cancer. Co-author DOI 10.1093/carcin/bgac060↗
  10. Thrombomodulin expression impacts the recurrence and long-term survival in pancreatic cancer. Co-author DOI 10.1002/ags3.12447↗
  11. The novel index using preoperative C-reactive protein and neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with pancreatic cancer. Co-author DOI 10.1007/s10147-021-01964-2↗
  12. Suppression of lysosomal acid alpha-glucosidase impacts the modulation of transcription factor EB translocation in pancreatic cancer. Co-author DOI 10.1111/cas.14921↗
  13. Inhibition of acid ceramidase elicits mitochondrial dysfunction and oxidative stress in pancreatic cancer cells. Co-author DOI 10.1111/cas.15123↗
  14. Incidental abdominal lymph node metastases from a known breast cancer in resected specimen of invasive pancreatic ductal adenocarcinoma: report of a case. Co-author DOI 10.1007/s13691-019-00382-6↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Toru Ikegami · 13 shared papers, 2021–2026 · strength 2.56
  2. Yoshihiro Shirai · 13 shared papers, 2021–2026 · strength 2.56
  3. Koichiro Haruki · 12 shared papers, 2019–2026 · strength 2.42
  4. Kenei Furukawa · 11 shared papers, 2021–2026 · strength 2.30
  5. Mitsuru Yanagaki · 10 shared papers, 2021–2026 · strength 2.09
  6. Ryoga Hamura · 8 shared papers, 2021–2026 · strength 1.27
  7. Shinji Onda · 6 shared papers, 2021–2026 · strength 1.25
  8. Yoshiaki Tanji · 5 shared papers, 2023–2026 · strength 1.17
  9. Masashi Tsunematsu · 5 shared papers, 2023–2026 · strength 1.14
  10. Michinori Matsumoto · 5 shared papers, 2019–2026 · strength 0.97
  11. Yosuke Igarashi · 3 shared papers, 2025–2026 · strength 0.79
  12. Tadashi Uwagawa · 4 shared papers, 2021–2025 · strength 0.63
  13. Taro Sakamoto · 3 shared papers, 2019–2025 · strength 0.51
  14. Takashi Horiuchi · 4 shared papers, 2021–2022 · strength 0.50
  15. Takeshi Gocho · 3 shared papers, 2021–2023 · strength 0.41
  16. Yuta Yamada · 1 shared paper, 2026 · strength 0.29
  17. Hiroaki Shiba · 2 shared papers, 2019–2021 · strength 0.24
  18. Katsuhiko K. Yanaga · 2 shared papers, 2019–2021 · strength 0.24
  19. Norimitsu Okui · 1 shared paper, 2024 · strength 0.21
  20. Shunta Ishizaki · 1 shared paper, 2024 · strength 0.21
  21. Kyohei Abe · 1 shared paper, 2023 · strength 0.15
  22. Hiroshi Sugano · 1 shared paper, 2021 · strength 0.13
  23. Nobuhiro Saito · 1 shared paper, 2021 · strength 0.12
  24. Shinji Tanaka · 1 shared paper, 2021 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.